Transcription of Madopar (levodopa) Data Sheet (DS) - Medsafe …
{{id}} {{{paragraph}}}
Madopar 160202 1 Data Sheet Madopar levodopa + benserazide Capsules , 125 and 250; dispersible tablet ; HBS modified-release capsule 125 Description Composition Active ingredient Madopar is a combination of levodopa and the decarboxylase inhibitor benserazide (as hydrochloride) in a ratio of 4:1. The preparation is available as capsules of three different strengths, as single scored dispersible tablets of one strength and as capsules with a controlled release action of one strength. Excipients Madopar , 125 and 250 capsules All three forms of the capsules contain microcrystalline cellulose, talc, povidone, magnesium stearate, gelatin, and the colourant(s) indigo carmine, titanium dioxide and iron oxide (red, yellow or black).
MADOPAR 160202 2 A No. 1 size capsule with a “ROCHE” imprint, an opaque caramel coloured body and an opaque powder-blue cap. Each capsule contains: 200mg levodopa and 57 mg benserazide hydrochloride
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}